Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Thrombosis Research|December 13, 2000
Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolismM Bozic, M Stegnar, I Fermo, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 16, 2001
Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery diseaseA Mavri, B Guzic-Salobir, B Salobir-Pajnic, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese womenA Mavri, M Stegnar, M Krebs, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 17, 2001
Screening for selective thrombin inhibitors in mushroomsB Doljak, M Stegnar, U Urleb, et al.
Die Pharmazie|October 12, 2001
Novel thrombin inhibitors with azaphenylalanine scaffoldA Zega, A Trampus-Bakija, M Fortuna, et al.
The Pharmacogenomics Journal|April 13, 2005
Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance doseD Herman, I Locatelli, I Grabnar, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 11, 2012
Nurr1 haplotypes are associated with femoropopliteal restenosis/re-occlusion after percutaneous transluminal angioplastyM Božič-Mijovski, M Bedenčič, M Stegnar, et al.
International Archives of Allergy and Immunology|January 1, 1997
Influence of degraded phosphatidylserine on binding of antiphospholipid antibodiesB Bozic, T Kveder, M Stegnar, et al.
Thrombosis and Haemostasis|June 3, 1998
The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolismM Stegnar, P Uhrin, P Peternel, et al.
Diabetologia|November 24, 2001
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight lossA Mavri, M C Alessi, D Bastelica, et al.
Pageof 4